These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 21849252)
1. Conscious sedation or general anaesthetic for intramuscular botulinum toxin injections in children - a two centre cross-sectional prospective audit. Forrester M; Srinivasan J; Mihrshahi S; Waugh M; O'Flaherty S; Rice J; Graham K; Scheinberg A Eur J Paediatr Neurol; 2012 Mar; 16(2):215-7. PubMed ID: 21849252 [No Abstract] [Full Text] [Related]
2. Conscious sedation or general anaesthetic for intramuscular botulinum toxin injections in children - a two centre cross-sectional prospective audit. Soudant DL; Staal HM; Witlox AM; Vles JS Eur J Paediatr Neurol; 2013 Mar; 17(2):219-20. PubMed ID: 22871256 [No Abstract] [Full Text] [Related]
3. Determining the technical and clinical factors associated with pain for children undergoing botulinum toxin injections under nitrous oxide and anesthetic cream. Brochard S; Blajan V; Lempereur M; Garlantezec R; Houx L; Le Moine P; Peudenier S; Lefranc J; Rémy-Néris O Eur J Paediatr Neurol; 2011 Jul; 15(4):310-5. PubMed ID: 21273098 [TBL] [Abstract][Full Text] [Related]
4. [Sedation-analgesia protocol for the injection of botulinum toxin A in cerebral palsy]. Cantador-Hornero M; Jiménez-Espuch P; de Torres-Garcia I; Contreras-Jiménez M; Martínez-Mezo GL; Morales de Los Santos JM; Fernández-Jurado MI; Tirado-Reyes M An Pediatr (Engl Ed); 2019 Nov; 91(5):317-327. PubMed ID: 30795881 [TBL] [Abstract][Full Text] [Related]
5. [Evaluation of analgesic protocol with nitrous oxide and EMLA cream during botulinum toxin injections in children]. Gambart G; Mette F; Pellot AS; Richard I Ann Readapt Med Phys; 2007 Jun; 50(5):275-9. PubMed ID: 17337081 [TBL] [Abstract][Full Text] [Related]
6. Effectiveness of nitrous oxide and analgesic cream (lidocaine and prilocaine) for prevention of pain during intramuscular botulinum toxin injections in children. Brochard S; Blajan V; Lempereur M; Le Moine P; Peudenier S; Lefranc J; Rémy-Néris O Ann Phys Rehabil Med; 2009 Dec; 52(10):704-16. PubMed ID: 19854692 [TBL] [Abstract][Full Text] [Related]
7. 'Effectiveness of sedation using nitrous oxide compared with enteral midazolam for botulinum toxin A injections in children'. Gubbay A; Langdon K Dev Med Child Neurol; 2009 Jun; 51(6):491-2; author reply 492. PubMed ID: 19416317 [No Abstract] [Full Text] [Related]
8. Strategies to decrease injection site pain in botulinum toxin therapy. Paracka L; Kollewe K; Wegner F; Dressler D J Neural Transm (Vienna); 2017 Oct; 124(10):1213-1216. PubMed ID: 28741118 [TBL] [Abstract][Full Text] [Related]
9. Prevention and treatment of pediatric pain and anxiety caused by botulinum neurotoxin A injections: Inadmissible without nitrous oxide analgesia and sedation? Friedrichsdorf SJ Dev Med Child Neurol; 2022 Dec; 64(12):1437-1438. PubMed ID: 36089662 [No Abstract] [Full Text] [Related]
10. Open-label study of botulinum toxin for upper limb spasticity in cerebral palsy. Wong V; Ng A; Sit P J Child Neurol; 2002 Feb; 17(2):138-42. PubMed ID: 11952075 [TBL] [Abstract][Full Text] [Related]
11. Systemic adverse events following botulinum toxin A therapy in children with cerebral palsy. Naidu K; Smith K; Sheedy M; Adair B; Yu X; Graham HK Dev Med Child Neurol; 2010 Feb; 52(2):139-44. PubMed ID: 20412252 [TBL] [Abstract][Full Text] [Related]
12. [Treatment with botulinum toxin in neurologic pediatrics]. Justus N; Lee SH; Berweck S; Heinen F Kinderkrankenschwester; 2007 Jul; 26(7):274-6. PubMed ID: 17726921 [No Abstract] [Full Text] [Related]
13. Constipation as an adverse event after botulinum toxin A treatment in children with cerebral palsy. Vles GF; Vles JSh Dev Med Child Neurol; 2010 Oct; 52(10):972; author reply 974. PubMed ID: 20561010 [No Abstract] [Full Text] [Related]
14. Effectiveness of sedation using nitrous oxide compared with enteral midazolam for botulinum toxin A injections in children. Zier JL; Rivard PF; Krach LE; Wendorf HR Dev Med Child Neurol; 2008 Nov; 50(11):854-8. PubMed ID: 19046178 [TBL] [Abstract][Full Text] [Related]
15. Use of botulinum toxin type A in pediatric patients with cerebral palsy: a three-center retrospective chart review. Gormley ME; Gaebler-Spira D; Delgado MR J Child Neurol; 2001 Feb; 16(2):113-8. PubMed ID: 11292216 [TBL] [Abstract][Full Text] [Related]
16. A French observational study of botulinum toxin use in the management of children with cerebral palsy: BOTULOSCOPE. Chaléat-Valayer E; Parratte B; Colin C; Denis A; Oudin S; Bérard C; Bernard JC; Bourg V; Deleplanque B; Dulieu I; Evrard P; Filipetti P; Flurin V; Gallien P; Héron-Long B; Hodgkinson I; Husson I; Jaisson-Hot I; Maupas E; Meurin F; Monnier G; Pérennou D; Pialoux B; Quentin V; Moreau MS; Schneider M; Yelnik A; Marque P Eur J Paediatr Neurol; 2011 Sep; 15(5):439-48. PubMed ID: 21745754 [TBL] [Abstract][Full Text] [Related]
17. Adverse events following botulinum toxin type A treatment in children with cerebral palsy. Langdon K; Blair E; Davidson SA; Valentine J Dev Med Child Neurol; 2010 Oct; 52(10):972-3; author reply 974. PubMed ID: 20561011 [No Abstract] [Full Text] [Related]
18. Experience with botulinum toxin in the treatment of cerebral palsy. Arens LJ; Leary PM; Goldschmidt RB S Afr Med J; 1997 Aug; 87(8):1001-3. PubMed ID: 9323408 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness of sedation using nitrous oxide compared with enteral midazolam for botulinum toxin A injections in children. Kumar R; Sneade C; Littler K Dev Med Child Neurol; 2009 Oct; 51(10):838-9. PubMed ID: 19747281 [No Abstract] [Full Text] [Related]
20. Effects of different dilutions of botulinum toxin type A treatment for children with cerebral palsy with spastic ankle plantarflexor: a randomized controlled trial. Lee JH; Sung IY; Yoo JY; Park EH; Park SR J Rehabil Med; 2009 Sep; 41(9):740-5. PubMed ID: 19774308 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]